GE Healthcare and Arineta Ltd Announce Partnership to Tackle Cardiovascular Disease

GE HealthcareGE Healthcare, a unit of General Electric Company (NYSE: GE), and Arineta Ltd. announced the formation of a strategic partnership in the area of computed tomography (CT) for cardiovascular applications.

Cardiovascular disease (CVD) continues to be the leading cause of death globally and has an enormous impact on public health and the healthcare delivery system. The goal of the partnership between the two companies is to develop solutions that will address this global challenge by improving the cost, access to and the quality of cardiac care.

"CT can be a viable, minimally-invasive imaging alternative for many cardiovascular procedures," said Steve Gray, VP and General Manager for GE Healthcare Global CT and Advantage Workstation. "We chose Arineta as a partner because we believe their cardiovascular imaging technology complements the GE Healthcare market-leading position in CT imaging."

Yosi Morik, Arineta co-founder and Chairman commented "We believe this collaboration with GE Healthcare provides the most effective path for Arineta to bring its cardiovascular imaging technologies to market."

Related news articles:

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $16 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

About Arineta Ltd
Arineta Ltd., based in Caesarea, Israel, is a privately owned start-up company focused on the development of advanced imaging systems for cardiovascular diagnosis and therapeutic applications. Arineta's mission is to develop clinically effective, reliable and safe solutions for cardiovascular imaging. Arineta systems are being developed to provide clear, sharp and accurate images - while optimizing dose, reducing discomfort to the patient, and lowering the cost of healthcare delivery. For more information about Arineta, see www.arineta.com.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...